Literature DB >> 24635551

A review of fMRI studies during visual emotive processing in major depressive disorder.

Natalia Jaworska1,2,3, Xiao-Ru Yang1,3, Verner Knott4, Glenda MacQueen1,2.   

Abstract

OBJECTIVES: This review synthesized literature on brain activity, indexed by functional magnetic resonance imaging (fMRI), during visual affective information processing in major depressive disorder (MDD). Activation was examined in regions consistently implicated in emotive processing, including the anterior cingulate cortex (ACC), prefrontal cortex (PFC), amygdala, thalamus/basal ganglia and hippocampus. We also reviewed the effects of antidepressant interventions on brain activity during emotive processing.
METHODS: Sixty-four fMRI studies investigating neural activity during visual emotive information processing in MDD were included.
RESULTS: Evidence indicates increased ventro-rostral ACC activity to emotive stimuli and perhaps decreased dorsal ACC activity in MDD. Findings are inconsistent for the PFC, though medial PFC hyperactivity tends to emerge to emotive information processing in the disorder. Depressed patients display increased amygdala activation to negative and arousing stimuli. MDD may also be associated with increased activity to negative, and decreased activity to positive, stimuli in basal ganglia/thalamic structures. Finally, there may be increased hippocampus activation during negative information processing. Typically, antidepressant interventions normalize these activation patterns.
CONCLUSION: In general, depressed patients have increased activation to emotive, especially negative, visual stimuli in regions involved in affective processing, with the exception of certain PFC regions; this pattern tends to normalize with treatment.

Entities:  

Keywords:  antidepressant; depression; emotion; gender; imaging

Mesh:

Year:  2014        PMID: 24635551     DOI: 10.3109/15622975.2014.885659

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  39 in total

1.  Lifetime major depression and grey-matter volume

Authors:  Marie-Laure Ancelin; Isabelle Carrière; Sylvaine Artero; Jerome Maller; Chantal Meslin; Karen Ritchie; Joanne Ryan; Isabelle Chaudieu
Journal:  J Psychiatry Neurosci       Date:  2019-01-01       Impact factor: 6.186

2.  Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.

Authors:  Leanne M Williams; Mayuresh S Korgaonkar; Yun C Song; Rebecca Paton; Sarah Eagles; Andrea Goldstein-Piekarski; Stuart M Grieve; Anthony W F Harris; Tim Usherwood; Amit Etkin
Journal:  Neuropsychopharmacology       Date:  2015-03-31       Impact factor: 7.853

3.  Functional network connectivity (FNC)-based generative adversarial network (GAN) and its applications in classification of mental disorders.

Authors:  Jianlong Zhao; Jinjie Huang; Dongmei Zhi; Weizheng Yan; Xiaohong Ma; Xiao Yang; Xianbin Li; Qing Ke; Tianzi Jiang; Vince D Calhoun; Jing Sui
Journal:  J Neurosci Methods       Date:  2020-05-04       Impact factor: 2.390

Review 4.  Precision psychiatry: a neural circuit taxonomy for depression and anxiety.

Authors:  Leanne M Williams
Journal:  Lancet Psychiatry       Date:  2016-04-14       Impact factor: 27.083

5.  Functional connectivity underpinnings of electroconvulsive therapy-induced memory impairments in patients with depression.

Authors:  Danhong Wang; Yanghua Tian; Meiling Li; Louisa Dahmani; Qiang Wei; Tongjian Bai; Franziska Galiè; Jianxun Ren; Rai Khalid Farooq; Kangcheng Wang; Jie Lu; Kai Wang; Hesheng Liu
Journal:  Neuropsychopharmacology       Date:  2020-05-20       Impact factor: 7.853

6.  Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.

Authors:  Jessica L Reed; Allison C Nugent; Maura L Furey; Joanna E Szczepanik; Jennifer W Evans; Carlos A Zarate
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-01-25

7.  Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles.

Authors:  Rosemary C Bagot; Hannah M Cates; Immanuel Purushothaman; Vincent Vialou; Elizabeth A Heller; Lynn Yieh; Benoit LaBonté; Catherine J Peña; Li Shen; Gayle M Wittenberg; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2016-06-18       Impact factor: 13.382

Review 8.  Defining biotypes for depression and anxiety based on large-scale circuit dysfunction: a theoretical review of the evidence and future directions for clinical translation.

Authors:  Leanne M Williams
Journal:  Depress Anxiety       Date:  2016-09-21       Impact factor: 6.505

9.  Frontoparietal processing of stress-relevant information differs in individuals with a negative cognitive style.

Authors:  Cecilia Westbrook; Elena G Patsenko; Jeanette A Mumford; Lyn Y Abramson; Richard J Davidson
Journal:  J Abnorm Psychol       Date:  2018-07

Review 10.  Sex differences in anxiety and depression clinical perspectives.

Authors:  Margaret Altemus; Nilofar Sarvaiya; C Neill Epperson
Journal:  Front Neuroendocrinol       Date:  2014-06-02       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.